SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-02
👔
Quoin Pharmaceuticals, Ltd.
@QNRX_InsiderForm 4 Filing: Carter Denise P. Buys $100K of $QNRX
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Quoin Pharmaceuticals, Ltd.
Ticker: $QNRX
Transaction Value
$100K
Price/Share: $4.88
transaction date
2026-08-31
Shares: 20,490
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Carter Denise P., holds the title of Chief Operating Officer at Quoin Pharmaceuticals, Ltd..
On 2026-08-31, the insider transacted 20,490 shares.The shares were transacted at a weighted average price of $4.88 per share, resulting in a total market-relevant value of $100K.
Executive Summary Summary
Carter Denise P. (Chief Operating Officer) bought $100K of $QNRX
Post-Transaction Position: 37,709 shares
SEC Accession No: 0001104659-26-104405 (CIK: 1958621)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.